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resumo A hemocromatose hereditária uma doença autossómica recessiva do 
metabolismo do ferro, geralmente associada à mutação C282Y no gene HFE. 
Presume-se que a origem desta mutação tenha ocorrido por acaso no 
haplótipo HLA-A*03-B*07 de um indivíduo do noroeste da Europa. O presente 
trabalho visou caracterizar a associação entre os alelos e haplótipos dos loci
HLA-A e -B com a mutação C282Y na população da ilha de São Miguel 
(Açores). Este estudo englobou 130 indivíduos, negativos para as mutações 
HFE H63D e S65C, que foram classificados em dois grupos: grupo C282Y (48 
homozigóticos ou portadores da C282Y) e grupo controlo (82 dadores de 
sangue sem as três mutações no gene HFE). Para todos os indivíduos, foi 
efectuado a genotipagem HLA-A e -B por PCR-SSP e a detecção das 
mutações HFE por PCR-RFLP. A análise estatística revelou que quatro alelos 
– A*03 (p=0.003, OR=3.33), A*26 (p=0.003, OR=8.38), A*29 (p<0.001, 
OR=19.18) e B*45 (p=0.003, OR=8.37) – encontram-se significativamente 
aumentados no grupo C282Y. Os resultados demonstram, igualmente, uma 
associação significativa com a mutação C282Y para o haplótipo ancestral 
HLA-A*03-B*07 (p=0.006, OR=8.96) e dois haplótipos não ancestrais: 
A*02-B*58 (p<0.001, OR=19.78) e A*29-B*45 (p<0.001, OR=27.57). Além 
disso, outro haplótipo A*24-B*15 foi detectado por inferência directa num 
doente homozigótico para o HLA-A-B e para a mutação C282Y. 
Provavelmente, o mecanismo genético de recombinação gerou esta 
diversidade de haplótipos; no entanto, não se pode excluir a hipótese de uma 
mutação C282Y de novo no gene HFE associada ao haplótipo HLA-A*24-B*15. 
Em conclusão, além do haplótipo ancestral A*03-B*07, três novos haplótipos –
A*02-B*58, A*24-B*15 e A*29-B*45 – sugerem estar associados à mutação 
C282Y na população da ilha de São Miguel. A elevada diversidade genética 
observada na população açoriana pode explicar a associação entre a mutação 
C282Y e os haplótipos HLA. 
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abstract 
 
Hereditary hemochromatosis is an autosomal recessive disease of the iron 
metabolism, where HFE C282Y is commonly implicated. This mutation seems 
to have originated by chance on the HLA-A*03-B*07 haplotype in a 
northwestern European individual, and spread by migration. Given that 
recombination generates new haplotypes, the present investigation aimed to 
characterize the chromosomal background of C282Y in the São Miguel Island 
population (Azores). This study comprises 130 individuals, all negative for 
H63D and S65C, which were classified into two groups: 48 homozygous or 
carriers for C282Y, and 82 healthy individuals without these mutations. The 
subjects were HLA-A and -B genotyped by PCR-SSP, and HFE mutation 
detection was performed by PCR-RFLP. Statistical analysis revealed that four 
alleles – A*03 (p=0.003, OR=3.33), A*26 (p=0.003, OR=8.38), A*29 (p<0.001, 
OR=19.18) and B*45 (p=0.003 OR=8.37) – and the A*03-B*07 haplotype 
(p=0.006, OR=8.96) were significantly increased in the C282Y group. Two 
non-ancestral haplotypes were also significantly associated with C282Y: 
A*02-B*58 (p<0.001, OR=19.78) and A*29-B*45 (p<0.001, OR=27.57). This 
last haplotype showed the strongest association to the mutation in study, 
suggesting that it may be the principal hemochromatosis-haplotype in São 
Miguel Island population. Another haplotype – A*24-B*15 – was detected by 
direct inference in a C282Y and HLA-A-B homozygous patient. Recombination 
most probably generated these haplotypes, before or after the island 
settlement. However, we can not exclude the hypothesis of a recent de novo
HFE C282Y mutation on the A*24-B*15 haplotype in an individual living in the 
São Miguel Island. Overall, in this population, besides the ancestral A*03-B*07, 
three new non-ancestral haplotypes – A*02-B*58, A*24-B*15 and A*29-B*45 –
appear to be associated with C282Y. The association between this recessive 
mutation and these haplotypes undoubtedly reflects the high genetic diversity 
observed in the Azoreans. 
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Abbreviations 
A Adenine 
Asp Aspartic acid 
bp Base pairs 
C Cytosine 
ºC Degrees Celsius  
C282Y Cys 282 Tyr  
CI Confidence interval 
Cys Cysteine 
DNA Deoxyribonucleic acid 
dNTP Deoxyribonucleotide triphospate 
G Guanine 
H63D His 63 Asp 
HFE Hemochromatosis gene 
HH Hereditary hemochromatosis 
His Histidine 
HLA Human leukocyte antigen 
MgCl2 Magnesium chloride 
min Minutes 
mL Millilitres 
mM Millimolar 
ng Nanograms 
OMIM Online mendelian inheritance in man 
OR Odds ratio 
PCR Polymerase chain reaction 
sec Seconds 
Ser Serine 
SSP Specific-sequence primer 
S65C Ser 65 Cys 
Tyr Tyrosine 
U Units 
µL Microlitres 
µM Micromolar 
% Percentage 
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1. INTRODUCTION 
Hereditary hemochromatosis (HH, OMIM 235200, HFE gene) is an autosomal 
recessive disease of the iron metabolism, common in northern European 
populations with a prevalence of 1 in 200-300 individuals (Adams et al., 2000; 
Camaschella et al., 2000). This disease is characterized by increased iron 
absorption and deposition in liver, pancreas, heart, joints and pituitary glands. If 
undiagnosed or untreated, death may occur due to cirrhosis, primary liver cancer, 
diabetes or cardiomyopathy. Early diagnosis and treatment can prevent the 
development of these clinical complications, allowing HH patients to have a normal 
life expectancy (Pietrangelo, 2006; Wheeler et al., 2006; Beutler, 2007). The HFE 
gene encodes an HLA-A class 1-like protein and is located on 6p21.3, 4 
megabases (Mb) telomeric to the human leukocyte antigen region (HLA). Two 
HFE mutations – C282Y (845 GA) and H63D (187 CG) – are significantly 
correlated with HH. The majority (60% to 90%) of clinically diagnosed probands 
are homozygous for C282Y, and 5% are compound heterozygous for C282Y and 
H63D. In terms of molecular pathology, the C282Y is the most severe mutation, as 
the mutated protein is unable to bind to the β2-microglobulin and, subsequently, its 
structure and function are affected (Feder et al., 1996). 
The C282Y mutation seems to have originated by chance, before 4000 BC, on a 
HLA-A*03-B*07 haplotype in an individual from northwestern Europe, and early 
spread by Celts or Vikings (Simon et al., 1980; Milman & Pederson, 2003; Distante 
et al., 2004). By recombination and admixture, this mutation has been also found 
in non-ancestral HLA haplotypes, which were reported with significantly increased 
frequencies in Europe and European descent hemochromatosis patients (Simon et 
al., 1987; Porto & de Sousa, 2000; Yaouanq, 2000; Barton & Acton, 2002). 
The aim of the present study was to determine the frequencies of HLA-A and -B 
alleles and haplotypes associated with the C282Y mutation, in order to 
characterize the chromosomal background of this recessive mutation in the São 
Miguel Island population (Azores). This population is composed, to a great extent, 
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of mainland Portuguese descent with significant contributions of Jews, Africans 
and Europeans (Pacheco et al., 2005; Spínola et al., 2005; Branco et al., 2006; 
Branco et al., 2008; Branco et al., 2008). 
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2. MATERIAL AND METHODS 
2.1. Population sample 
The population sample, composed of 130 individuals from the São Miguel Island 
(Azores, Portugal), were divided into two groups, as follows: the C282Y mutated 
group with 36 heterozygous and 12 homozygous identified on medical care basis, 
and the control group of 82 apparently healthy blood donors (Mota-Vieira et al., 
2005). All individuals were negative for the H63D and S65C mutations. 
2.2. DNA extraction and HFE mutation analysis 
Peripheral blood samples (7.5 mL) were collected by venipuncture into EDTA 
tubes and genomic DNA was extracted using the PUREGENE® kit (Gentra 
systems Inc.) from iron overload patients with presumptive clinical diagnosis of 
hemochromatosis.  
The C282Y, H63D and S65C mutation detection was carried out by polymerase 
chain reaction (PCR), as previously described (Feder et al., 1996), and followed by 
specific restriction enzyme. The primer sequences used were: 5´-TGG CAA GGG 
TAA ACA GAT CC-3´ (forward) and 5´-CTC AGG CAC TCC TCT CAA CC-3´ 
(reverse) for the C282Y (exon 4), and 5´-ACA TGG TTA AGG CCT GTT GC-3´ 
(forward) and 5´-GCC ACA TCT GGC TTG AAA TT-3´ (reverse) for the H63D and 
S65C (exon 2). The PCR amplifications were performed in a 20 µL reaction 
mixture including 1 x PCR buffer, 1 x Q-solution, 2.5 mM MgCl2, 0.2 mM dNTP, 1.0 
µM of forward and reverse amplification primers, 0.60 U of HotStarTaq DNA 
polymerase (QIAGEN) and 100 ng of genomic DNA, according to these 
conditions: 15 min at 95 ºC for initial denaturation and DNA polymerase activation 
followed by 35 cycles of 30 sec at 94 ºC for denaturation, 30 sec at 56.5 ºC for 
annealing, and 1 min at 72 ºC for extension; the last extension was carried out 
during 10 min at 72 ºC. The PCR products from exons 2 (208 base pairs, bp, for 
H63D and S65C) and 4 (390 bp for C282Y) were digested for 2 hours at 37 ºC 
with RsaI for C282Y, MboI for H63D and HinfI for S65C (New England Biolabs). 
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The digestion products were size resolved by electrophoresis on 4% agarose gel 
and visualized by SYBR® Green I nucleic acid gel stain (Molecular Probes). For 
the C282Y, the RsaI produced two fragments of 250 and 140 bp in the wild type 
DNA and three fragments of 250, 111 and 29 bp in the mutated DNA. In the case 
of wild type DNA for H63D, the MboI generated two fragments of 138 and 70 bp, 
whereas for HinfI the two fragments have 147 and 61 bp; both H63D and S65C 
mutated DNA were not cut. 
2.3. HLA genotyping 
HLA-A and -B genotyping was performed in the 130 individuals by PCR-SSP 
Olerup SSP™ (GenoVision Inc.), according to the manufacturers’ instructions. 
After electrophoresis on a 4% agarose gel stained with SYBR® Green, the PCR 
products were visualized, followed by HLA allele identification using the Helmberg-
SCORETM “Sequence Compilation and Rearrangment Evaluation for Research 
only” software version 3.320T (Olerup SSP AB, Saltsjöbaden, Sweden). 
2.4. Statistical analysis 
The HLA-A and -B allele and haplotype frequencies were calculated using the 
Arlequin version 3.1 software (Excoffier et al., 2005). The haplotype frequencies, 
from multilocus genotype data, were computed using the Expectation-
Maximization algorithm because, except for one individual, the gametic phase was 
unknown. The presence of association between the C282Y mutation and HLA 
alleles and haplotypes was estimated by Chi-square or Fisher´s tests, as 
appropriate, using GraphPad Prism software, version 5.01 for Windows, San 
Diego California USA (www.graphpad.com). A p<0.05 was considered as 
statistically significant. Odds ratio (OR) were also determined using the Odds 
Ratio Generator software, version 1.0 for windows (Devilly, 2005). 
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3. RESULTS 
3.1. HLA-A and -B allele frequencies 
A total of 130 individuals were HLA-A and -B genotyped in order to characterize 
the chromosomal background of the C282Y mutation in the São Miguel Island 
(Azores). The -A genotyping revealed 12 different alleles in the C282Y group 
(Appendix 1) and 16 in the control population. Only the A*28 was absent in the 
control population. The C282Y group has 11 homozygous individuals for the 
following alleles: A*02 (n=4), A*03 (n=6) and A*24 (n=1). The four most frequent 
observed in this group were A*02 (0.2917), A*03 (0.2083), A*01 (0.1250) and A*29 
(0.1042). When we compare both groups, three alleles showed significant 
association with the C282Y mutation, namely: A*03 (p=0.003, OR=3.33, 95 % CI: 
1.55–7.18), A*26 (p=0.003, OR=8.38, 95% CI: 1.77–39.64) and A*29 (p<0.001, 
OR=19.18, 95% CI: 2.41–152.32). This last allele has the strongest association 
with C282Y mutation. 
Twenty HLA-B alleles were identified in the C282Y group in comparison with the 
control population (Appendix 2). Three C282Y individuals were homozygous for 
B*07, B*15 and B*44. The five most frequent alleles observed in the C282Y group 
were B*14 (0.0938), B*18 (0.0938), B*45 (0.0938), B*07 (0.0729) and B*08 
(0.0729). From all alleles, only the B*45 was found to be statistically significant 
(p=0.003) and presented a strong association with the C282Y mutation (OR=8.37, 
95% CI: 1.77–39.64). 
3.2. HLA-A and -B haplotypes 
The HLA-A and -B haplotype determination was performed to investigate which of 
them appeared to be associated with HFE C282Y mutation. A total of 106 different 
haplotypes were found in the population sample, being 29 (27.36%, Appendix 3) 
and 59 (55.66%, data not shown) only observed in the mutated and control 
groups, respectively.  
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The five most frequent haplotypes in the C282Y group were A*29-B*45 (0.0729), 
A*01-B*08 (0.0521), A*02-B*44 (0.0521), A*02-B*58 (0.0521) and A*03-B*07 
(0.0521). Homozygosity was detected in two C282Y carriers for A*02-B*44 and 
A*03-B*07, and in one patient for A*24-B*15, being this last one a new 
non-ancestral haplotype. We found two other non-ancestral haplotypes – 
A*02-B*58 (p<0.001, OR=19.78, 95% CI: 1.08–362.00) and A*29-B*45 (p<0.001, 
OR=27.57, 95% CI: 1.56–488.70) –, both absent in the control population. The 
results also demonstrate that the ancestral A*03-B*07 haplotype was significantly 
increased in the C282Y group, when compared to the controls (p=0.006, OR=8.96, 
95% CI: 1.03–77.84). Altogether, four HLA haplotypes associated with C282Y 
mutation were identified in the São Miguel Island population. However, due to the 
relatively low number of population sample, the OR estimated are significant, but 
some upper confidence intervals indicate that a strong conclusion can not be 
drawn. 
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4. DISCUSSION AND CONCLUSION 
Extensive studies – population and family based – have been performed in several 
geographical areas to characterize the origin of HFE C282Y mutation through HLA 
haplotyping (Yaouanq, 2000; Barton & Acton; 2002; Olsson et al., 2008). These 
studies suggest that this mutation occurred once on a particular chromosome 
carrying the A*03-B*07 haplotype in northwestern Europe. By recombination and 
admixture, this ancestral haplotype has subsequently been modified, generating 
other HLA haplotypes: A*03 and non-A*03 bearing (Simon et al., 1987). In the 
present study, we describe the HLA haplotypes associated with C282Y mutation in 
the population living on the Azorean Island of São Miguel, located in the North 
Atlantic Ocean. The HFE mutation detection – C282Y, H63D and S65C – was 
determinant to increase the power of the population sample studied, assuring that 
the mutated group was only composed of C282Y subjects and the control group 
were negative for the three mutations. Due to the diminutive number of 
homozygous, the C282Y mutated group comprised homozygous and 
heterozygous individuals, even though homozygous are the ideal to study HLA 
haplotype associations (Pacho et al., 2004). 
In the São Miguel Island population, the C282Y mutation seems to be associated 
with four haplotypes. One of them – A*03-B*07 – is the ancestral and the most 
common haplotype in hemochromatosis patients (Barton & Acton, 2002; Yaouanq, 
2000). With time, the recombination of this haplotype with other B-alleles 
generated new HLA-A*03 haplotypes that migrated with the mutation (Simon et al., 
1987). Here, seven HLA-A*03 bearing haplotypes – A*03-B*18, A*03-B*27, 
A*03-B*50, A*03-B*51, A*03-B*53, A*03-B*55 and A*03-B*57 – were only present 
in the C282Y group. From these, four were previously described in patients from 
other regions, namely: A*03-B*18 and A*03-B*51 in mainland Portugal (Cruz et al., 
2006) and A*03-B*27 and A*03-B*57 in Alabama (Barton & Acton, 2002). Knowing 
the strategic position of the Azores, the presence of these HLA-A*03 haplotypes in 
São Miguel Island may be explained by the admixture of their inhabitants, 
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descendants from individuals of different origins, including the first settlers of the 
15th and 16th centuries. 
The present study also revealed three new non-ancestral haplotypes –A*02-B*58, 
A*24-B*15 and A*29-B*45 –, being the last one the most frequent (7.29%) and 
presenting the strongest association with the mutation (p<0.001, OR=27.57, 95% 
CI: 1.56–488.70). These findings suggest that A*29-B*45 haplotype appeared 
predominantly linked to the C282Y in the São Miguel Island population. 
Considering that this population is mainly of Portuguese descent, the A*29-B*45 
may have arisen by recombination of the A*29-B*37 reported in mainland (Cruz et 
al., 2006). Even though rarely associated with the C282Y, the A*29 was found in 
linkage disequilibrium with two other HFE mutations, the H63D in the mainland 
(Cardoso et al., 2002) and the S65C in the Azorean Island of Terceira (Couto et 
al., 2003). Other non-ancestral haplotypes – A*01-B*08 and A*11-B*35 – have 
also been identified in specific geographical areas, such as Sweden (Olsson et al., 
2007; Olsson et al., 2008) and Brittany (Simon et al., 1987), respectively. Although 
the evolution mechanisms underlying these associations remain unclear, the 
non-A*03 haplotypes are thought to originate from recent recombinations (Cruz et 
al., 2006; Yaouanq, 2000). 
HLA genotyping of the twelve C282Y homozygous patients revealed, by direct 
inference, the A*24-B*15. To our knowledge this is a new haplotype, generated 
probably by recombination, and reinforces the association between C282Y and 
A*24 (-B*18, -B*35 and -B*57) detected in mainland Portuguese homozygous 
patients (Cruz et al., 2006). However, we can not exclude the hypothesis of a de 
novo mutation on the A*24-B*15, because this haplotype was also present in our 
control population. Most likely, one of these events occurred recently in an 
individual living in the São Miguel, since it only appeared in one homozygous 
patient.  
In the Spanish population, Pacho and colleagues (2004) considered protector 
haplotypes, those present with high frequency in the control group and absent in 
C282Y homozygous individuals. According to these criteria, in São Miguel 
population we could consider five protector haplotypes: A*02-B*35 (3.35%), 
 17 
A*01-B*51 (3.05%), A*68-B*49 (3.05%), A*30-B*18 (2.44%) and A*68-B*15 
(2.44%).  
In summary, this study suggest that in São Miguel population the C282Y mutation 
is not only associated with the ancestral haplotype – A*03–B*07 –, but also with 
three new non-ancestral A*29-B*45, A*02-B*58 and A*24-B*15 haplotypes. 
Recombination most probably generated these haplotypes, before or after 
settlement. However, we also hypothesize a recent de novo HFE C282Y mutation 
on the A*24-B*15 haplotype in an individual living in São Miguel Island. The 
existence of several haplotypes associated with this recessive mutation is 
corroborated by the Azorean high genetic diversity. 
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5. PERSPECTIVES 
The present thesis is part of an ongoing research project on the genetic features of 
hereditary hemochromatosis in the São Miguel Island population (Azores). During 
the last five years, this population has been the object of several studies, 
concerning in particular its genetic structure and diversity.  
Here, we demonstrate that the principal mutation implicated with the hereditary 
hemochromatosis – the C282Y on HFE gene – may be associated with several 
HLA-A-B haplotypes, namely A*03-B*07, A*02-B*58, A*24-B*15 and A*29-B*45. 
However, a further study with an increase sample size would contribute to narrow 
the confidence intervals observed in some odds ratio values. Nevertheless, the 
scientific information obtained can be used in planning investigations of other 
recessive mutations, as well as in the characterization of the molecular 
consanguinity in the São Miguel Island population. 
Furthermore, this HLA-hemochromatosis association study has lead to the 
initiation of another research project, the HLA (class II) susceptibility with 
leptospirosis, an infectious disease which is a severe public health problem in the 
São Miguel and Terceira Islands. 
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APPENDICES 
 
Appendix 1. HLA-A allele frequencies in the HFE C282Y mutated and control 
groups 
 
  Allele frequencies     
HLA 
 C282Y 
(n=96) 
Controls 
(n=164)  
 p-value 
(Chi-square) 
 
OR (95% CI) 
A*01  0.1250 0.1585  NS    0.76 
A*02  0.2917 0.2805  NS    1.05 
A*03  0.2083 0.0732  0.003    3.33 (1.55–7.18) 
A*11  0.0312 0.0549  NS    0.55 
A*24  0.0938 0.1037  NS    0.89 
A*26  0.0208 0.0122  0.003    8.38 (1.77–39.64) 
A*28  0.0104 0.0000  NS    5.17 
A*29  0.1042 0.0061  <0.001  19.18 (2.41–152.32) 
A*31  0.0208 0.0183  NS    1.14 
A*33  0.0417 0.0183  NS    2.33 
A*66  0.0104 0.0061  NS    1.72 
A*68  0.0417 0.0976  NS    0.40 
n: total number of chromosomes in each group, OR: Odds ratio, CI: Confidence interval, p: 
Significance level, NS: Not significant. 
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Appendix 2. HLA-B allele frequencies in the HFE C282Y mutated and control 
groups 
 
  Allele frequencies     
HLA 
 C282Y 
(n=96) 
Controls 
(n=164)  
 p-value 
(Chi-square) 
 
OR (95% CI) 
B*07  0.0729 0.0610  NS  1.21 
B*08  0.0729 0.1220  NS  0.57 
B*13  0.0208 0.0122  NS  1.72 
B*14  0.0938 0.0732  NS  1.31 
B*15  0.0312 0.0549  NS  0.55 
B*18  0.0938 0.0427  NS  2.32 
B*27  0.0521 0.0305  NS  1.75 
B*35  0.0625 0.0793  NS  0.77 
B*37  0.0312 0.0061  NS  5.26 
B*38  0.0104 0.0244  NS  0.42 
B*40  0.0312 0.0488  NS  0.63 
B*44  0.0521 0.1341  NS  0.35 
B*45  0.0938 0.0122  0.003   8.37 (1.77–39.64) 
B*49  0.0521 0.0549  NS  1.07 
B*50  0.0104 0.0427  NS  0.24 
B*51  0.0417 0.0976  NS  0.40 
B*53  0.0208 0.0183  NS  1.14 
B*55  0.0521 0.0122  NS  4.45 
B*57  0.0521 0.0183  NS  2.95 
B*58  0.0521 0.0183  NS  2.95 
n: total number of chromosomes in each group, OR: Odds ratio, CI: Confidence interval, p: 
Significance level, NS: Not significant. 
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Appendix 3. HLA-A-B haplotype frequencies in the HFE C282Y mutated and 
control groups 
 
  Haplotype frequencies     
HLA 
 C282Y 
(n=96) 
Controls 
(n=164)  
 p-value 
(Chi-square) 
 
OR (95% CI) 
A*01-B*08  0.0521 0.0976  NS   0.51 
A*01-B*14  0.0104 0.0061  NS   1.72 
A*01-B*35  0.0313 0.0000  NS  12.32 
A*01-B*57  0.0313 0.0061  NS    5.26 
A*02-B*07  0.0104 0.0000  NS    5.17 
A*02-B*13  0.0104 0.0061  NS    1.72 
A*02-B*14  0.0238 0.0000  NS    8.70 
A*02-B*38  0.0104 0.0122  NS    0.85 
A*02-B*40  0.0208 0.0244  NS    0.85 
A*02-B*44  0.0521 0.0938  NS    0.55 
A*02-B*45  0.0104 0.0000  NS    5.17 
A*02-B*49  0.0283 0.0000  NS  12.32 
A*02-B*51  0.0313 0.0272  NS    1.29 
A*02-B*55  0.0417 0.0000  NS  16.01 
A*02-B*58  0.0521 0.0000  <0.001  19.78 (1.08–362.00) 
A*03-B*07  0.0521 0.0061  0.006    8.96 (1.03–77.84) 
A*03-B*14  0.0283 0.0122  NS    2.61 
A*03-B*18  0.0208 0.0000  NS    8.70 
A*03-B*27  0.0208 0.0000  NS    8.70 
A*03-B*35  0.0104 0.0183  NS    0.56 
A*03-B*49  0.0134 0.0061  NS    1.71 
A*03-B*50  0.0104 0.0000  NS    5.17 
A*03-B*51  0.0104 0.0000  NS    5.17 
A*03-B*53  0.0104 0.0000  NS    5.17 
A*03-B*55  0.0104 0.0000  NS    5.17 
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Appendix 3. (cont.) HLA-A-B haplotype frequencies in the HFE C282Y mutated 
and control groups 
 
 
  Haplotype frequencies     
HLA 
 C282Y 
(n=96) 
Controls 
(n=164)  
 p-value 
(Chi-square) 
 
OR (95% CI) 
A*03-B*57  0.0208 0.0000  NS    8.7 
A*11-B*18  0.0104 0.0000  NS    5.17 
A*11-B*35  0.0104 0.0122  NS    0.85 
A*11-B*37  0.0104 0.0000  NS    5.17 
A*24-B*08  0.0104 0.0244  NS    0.42 
A*24-B*15a  0.0313 0.0061  0.006    5.25 (0.54–51.28) 
A*24-B*18  0.0313 0.0000  NS  12.32 
A*24-B*27  0.0104 0.0108  NS    0.85 
A*24-B*35  0.0104 0.0136  NS    0.85 
A*26-B*49  0.0104 0.0000  NS    5.17 
A*26-B*53  0.0104 0.0000  NS    5.17 
A*28-B*37  0.0104 0.0000  NS    5.17 
A*29-B*08  0.0104 0.0000  NS    5.17 
A*29-B*27  0.0208 0.0000  NS    8.70 
A*29-B*45  0.0729 0.0000  <0.001  27.57 (1.56–488.70) 
A*31-B*07  0.0104 0.0000  NS    5.17 
A*31-B*13  0.0104 0.0000  NS    5.17 
A*33-B*14  0.0313 0.0122  NS    2.61 
A*33-B*45  0.0104 0.0000  NS    5.17 
A*66-B*40  0.0104 0.0000  NS    5.17 
A*68-B*18  0.0313 0.0000  NS  12.32 
A*68-B*37  0.0104 0.0000  NS    5.17 
a
 This haplotype is also associated with C282Y, since patient was homozygous for HLA-A and -B 
alleles, n: total number of chromosomes in each group, OR: Odds ratio, CI: Confidence interval, p: 
Significance level, NS: Not significant. 
